This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Université Paris Diderot-Paris 7, Universite Paris Xiii Paris-Nord. Active years: 2018.
Company Filing History:
1 out of 1,853 
1 out of 111 
1 out of 8 Years Active: 2018
Title: Benoit Ho-Tin-Noe: Innovator in Thrombotic Disease Solutions
Introduction
Benoit Ho-Tin-Noe is a notable inventor based in Paris, France. He has made significant contributions to the field of thrombotic diseases through his innovative research and inventions. His work focuses on developing targeted therapies that can improve patient outcomes in thrombotic conditions.
Latest Patents
Benoit Ho-Tin-Noe holds a patent for "Aminofucoidan as a vector for fibrinolysis in thrombotic diseases." This invention relates to a vector that targets thrombus, featuring t-PA binding properties. The vector consists of a thrombus-targeting fucoidan moiety, which is covalently linked to one or more t-PA binding amino groups by the reducing end of the fucoidan moiety. This innovative approach has the potential to enhance the treatment of thrombotic diseases.
Career Highlights
Throughout his career, Benoit has worked with esteemed institutions such as Université Paris XIII Paris-Nord and Université Paris Diderot-Paris 7. His academic background and research experience have played a crucial role in his development as an inventor in the medical field.
Collaborations
Benoit has collaborated with notable colleagues, including Didier Letourneur and Martine Jandrot-Perrus. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Benoit Ho-Tin-Noe is a distinguished inventor whose work in thrombotic diseases showcases the importance of innovation in medical research. His contributions have the potential to significantly impact patient care and treatment options in this critical area of health.